Cohance Lifesciences management will engage with analysts and institutional investors at two separate conferences scheduled in Mumbai during June 2026. The company confirmed that no unpublished price-sensitive information will be shared during these interactions.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cohance Lifesciences disclosed the schedule for the upcoming meetings. The management will participate in both group and one-on-one sessions at the events.

Conference Schedule

The company noted that the schedule for these meetings is subject to change due to exigencies on the part of analysts, institutional investors, or the company. The intimation was signed by Sisir K. Mishra, Company Secretary & Compliance Officer.

Cohance Lifesciences Limited will engage with analysts and institutional investors across three conferences scheduled for May and June 2026. The management will attend meetings in Mumbai and Hyderabad to discuss business performance and strategy, ensuring no unpublished price-sensitive information is shared during these interactions.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company disclosed the schedule to the stock exchanges. The meetings include participation in the 360 ONE Capital (B&K) 16th Annual Investor Conference - Trinity India 2026, the BofA Healthcare Tour, and the Goldman Sachs CRO/CDMO Tour.

The following table details the scheduled conferences:

A revision was noted for the 360 ONE Capital Conference, where meetings were rescheduled from the earlier disclosed date of May 27 to May 29, 2026. The company indicated that the schedule remains subject to change due to exigencies on the part of analysts, institutional investors, or the company.

Sisir K. Mishra, Company Secretary & Compliance Officer, signed the disclosure on behalf of Cohance Lifesciences Limited. The corporate office is located in Hyderabad, while the registered office is based in Mumbai.